Human cardiovascular progenitor cells develop from a KDR+ embryonic-stem-cell-derived population
The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
The functional heart is comprised of distinct mesoderm-derived lineages including cardiomyocytes, endothelial cells and vascular smooth muscle cells. Studies in the mouse embryo and the mouse embryonic stem cell differentiation model have provided evidence indicating that these three lineages develop from a common Flk-1(+) (kinase insert domain protein receptor, also known as Kdr) cardiovascular progenitor that represents one of the earliest stages in mesoderm specification to the cardiovascular lineages. To determine whether a comparable progenitor is present during human cardiogenesis, we analysed the development of the cardiovascular lineages in human embryonic stem cell differentiation cultures. Here we show that after induction with combinations of activin A, bone morphogenetic protein 4 (BMP4), basic fibroblast growth factor (bFGF, also known as FGF2), vascular endothelial growth factor (VEGF, also known as VEGFA) and dickkopf homolog 1 (DKK1) in serum-free media, human embryonic-stem-cell-derived embryoid bodies generate a KDR(low)/C-KIT(CD117)(neg) population that displays cardiac, endothelial and vascular smooth muscle potential in vitro and, after transplantation, in vivo. When plated in monolayer cultures, these KDR(low)/C-KIT(neg) cells differentiate to generate populations consisting of greater than 50% contracting cardiomyocytes. Populations derived from the KDR(low)/C-KIT(neg) fraction give rise to colonies that contain all three lineages when plated in methylcellulose cultures. Results from limiting dilution studies and cell-mixing experiments support the interpretation that these colonies are clones, indicating that they develop from a cardiovascular colony-forming cell. Together, these findings identify a human cardiovascular progenitor that defines one of the earliest stages of human cardiac development.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“CMs can reliably be derived from human embryonic stem cells (ESCs) and induced pluripotent stem cells (iPSCs) using protocols that involve timed application of GFs or small molecules, that are designed to recapitulate developmental pathways.”
From Cardiovascular disease models: A game changing paradigm in drug discovery and screening (2019) · cites this paper as [148]
Citations
Cites
Laflamme, M. A., Chen, K. Y., Naumova, A. V., Muskheli, V., Fugate, J. A., Dupras, S. K., Reinecke, H., Xu, C., Hassanipour, M., Police, S., et al. (2007) · Nature Biotechnology · doi:10.1038/nbt1327 · Cited by 2,206
Bone morphogenetic protein-4 is required for mesoderm formation and patterning in the mouse.
Winnier, G., Blessing, M., Labosky, P. A., & Hogan, B. L. (1995) · Genes & Development · doi:10.1101/gad.9.17.2105 · Cited by 1,788
Cai, C.-L., Liang, X., Shi, Y., Chu, P.-H., Pfaff, S. L., Chen, J., & Evans, S. (2003) · Developmental Cell · doi:10.1016/s1534-5807(03)00363-0 · Cited by 1,610
Moretti, A., Caron, L., Nakano, A., Lam, J. T., Bernshausen, A., Chen, Y., Qyang, Y., Bu, L., Sasaki, M., Martin-Puig, S., et al. (2006) · Cell · doi:10.1016/j.cell.2006.10.029 · Cited by 1,038
Bearzi, C., Rota, M., Hosoda, T., Tillmanns, J., Nascimbene, A., De Angelis, A., Yasuzawa-Amano, S., Trofimova, I., Siggins, R. W., LeCapitaine, N., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0706760104 · Cited by 980
Requirement for Wnt3 in vertebrate axis formation
Liu, P., Wakamiya, M., Shea, M. J., Albrecht, U., Behringer, R. R., & Bradley, A. (1999) · Nature Genetics · doi:10.1038/11932 · Cited by 901
Lints, T. J., Parsons, L. M., Hartley, L., Lyons, I., & Harvey, R. P. (1993) · Development · doi:10.1242/dev.119.2.419 · Cited by 861
Conlon, F. L., Lyons, K. M., Takaesu, N., Barth, K. S., Kispert, A., Herrmann, B., & Robertson, E. J. (1994) · Development · doi:10.1242/dev.120.7.1919 · Cited by 770
Kattman, S. J., Huber, T. L., & Keller, G. M. (2006) · Developmental Cell · doi:10.1016/j.devcel.2006.10.002 · Cited by 729
Self-citationRole of the NF-ATc transcription factor in morphogenesis of cardiac valves and septum
de la Pompa, J. L., Timmerman, L. A., Takimoto, H., Yoshida, H., Elia, A. J., Samper, E., Potter, J., Wakeham, A., Marengere, L., Langille, B. L., et al. (1998) · Nature · doi:10.1038/32419 · Cited by 660
Cited by
Stem cells: past, present, and future
Zakrzewski, W., Dobrzyński, M., Szymonowicz, M., & Rybak, Z. (2019) · Stem Cell Research & Therapy · doi:10.1186/s13287-019-1165-5 · Cited by 1,834
Lian, X., Zhang, J., Azarin, S. M., Zhu, K., Hazeltine, L. B., Bao, X., Hsiao, C., Kamp, T. J., & Palecek, S. P. (2013) · Nature Protocols · doi:10.1038/nprot.2012.150 · Cited by 1,748
Lian, X., Hsiao, C., Wilson, G., Zhu, K., Hazeltine, L. B., Azarin, S. M., Raval, K. K., Zhang, J., Kamp, T. J., & Palecek, S. P. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1200250109 · Cited by 1,717
“The number of contracting EBs was assessed visually using a microscope with a 37 °C-heated stage.”
InfluentialChemically defined generation of human cardiomyocytes
Burridge, P. W., Matsa, E., Shukla, P., Lin, Z. C., Churko, J. M., Ebert, A. D., Lan, F., Diecke, S., Huber, B., Mordwinkin, N. M., et al. (2014) · Nature Methods · doi:10.1038/nmeth.2999 · Cited by 1,606
Functional Cardiomyocytes Derived From Human Induced Pluripotent Stem Cells
Zhang, J., Wilson, G. F., Soerens, A. G., Koonce, C. H., Yu, J., Palecek, S. P., Thomson, J. A., & Kamp, T. J. (2009) · Circulation Research · doi:10.1161/circresaha.108.192237 · Cited by 1,407
Laflamme, M. A., & Murry, C. E. (2011) · Nature · doi:10.1038/nature10147 · Cited by 1,206
Kattman, S. J., Witty, A. D., Gagliardi, M., Dubois, N. C., Niapour, M., Hotta, A., Ellis, J., & Keller, G. (2011) · Cell Stem Cell · doi:10.1016/j.stem.2010.12.008 · Cited by 1,159
Self-citationHu, B.-Y., Weick, J. P., Yu, J., Ma, L.-X., Zhang, X.-Q., Thomson, J. A., & Zhang, S.-C. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0910012107 · Cited by 1,013
Biowire: a platform for maturation of human pluripotent stem cell–derived cardiomyocytes
Nunes, S. S., Miklas, J. W., Liu, J., Aschar-Sobbi, R., Xiao, Y., Zhang, B., Jiang, J., Massé, S., Gagliardi, M., Hsieh, A., et al. (2013) · Nature Methods · doi:10.1038/nmeth.2524 · Cited by 952
Self-citationBraveheart, a Long Noncoding RNA Required for Cardiovascular Lineage Commitment
Klattenhoff, C. A., Scheuermann, J. C., Surface, L. E., Bradley, R. K., Fields, P. A., Steinhauser, M. L., Ding, H., Butty, V. L., Torrey, L., Haas, S., et al. (2013) · Cell · doi:10.1016/j.cell.2013.01.003 · Cited by 913
“Together, PdgfRa and Flk-1 define an early multipotent cardiovascular progenitor population (marked by MesP1), and their coexpression enhances cardiogenic potential (Kattman et al., 2006; Yang et al., 2008).”
BackgroundMaking muscle: skeletal myogenesis in vivo and in vitro
Chal, J., & Pourquié, O. (2017) · Development · doi:10.1242/dev.151035 · Cited by 825
“…hematopoietic progenitor specification and they established the role of Wnt signaling for mesoderm induction in vitro (Chadwick et al., 2003; Gadue et al., 2006; Johansson and Wiles, 1995; Kattman et al., 2011; Lindsley et al., 2006; Nakanishi et al., 2009; Yang et al., 2008; Zhang et al., 2008).”
BackgroundMa, J., Guo, L., Fiene, S. J., Anson, B. D., Thomson, J. A., Kamp, T. J., Kolaja, K. L., Swanson, B. J., & January, C. T. (2011) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00694.2011 · Cited by 770
“hiPSC-derived cardiomyocytes, as well as those derived from human embryonic stem cells (hESCs), also provide in vitro platforms for drug discovery and potentially for regenerative therapies (1, 43, 48).”
BackgroundMummery, C. L., Zhang, J., Ng, E. S., Elliott, D. A., Elefanty, A. G., & Kamp, T. J. (2012) · Circulation Research · doi:10.1161/circresaha.110.227512 · Cited by 713
Patient-specific induced pluripotent stem cells as a model for familial dilated cardiomyopathy
Sun, N., Yazawa, M., Liu, J., Han, L., Sanchez-Freire, V., Abilez, O. J., Navarrete, E. G., Hu, S., Wang, L., Lee, A., et al. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003552 · Cited by 696
Patient-specific induced pluripotent stem-cell-derived models of LEOPARD syndrome
Carvajal-Vergara, X., Sevilla, A., D’Souza, S. L., Ang, Y.-S., Schaniel, C., Lee, D.-F., Yang, L., Kaplan, A. D., Adler, E. D., Rozov, R., et al. (2010) · Nature · doi:10.1038/nature09005 · Cited by 690
Self-citationBurridge, P. W., Keller, G., Gold, J. D., & Wu, J. C. (2012) · Cell Stem Cell · doi:10.1016/j.stem.2011.12.013 · Cited by 670
“Using this method, approximately 70% of HES2 EBs spontaneously contract (Yang et al., 2008).”
Self-citationTiburcy, M., Hudson, J. E., Balfanz, P., Schlick, S., Meyer, T., Chang Liao, M.-L., Levent, E., Raad, F., Zeidler, S., Wingender, E., et al. (2017) · Circulation · doi:10.1161/circulationaha.116.024145 · Cited by 645
“In fact, to our knowledge, the following maturation characteristics have not been reported so far: (1) structural maturation with a rod-shaped CM morphology and sarcomers with distinguishable M bands; both parameters are rarely observed even in extended (1-year) monolayer cultures45; (2) dominant ventricular structura…”
BackgroundMethodInfluentialSelf-citationLan, F., Lee, A. S., Liang, P., Sanchez-Freire, V., Nguyen, P. K., Wang, L., Han, L., Yen, M., Wang, Y., Sun, N., et al. (2013) · Cell Stem Cell · doi:10.1016/j.stem.2012.10.010 · Cited by 667
“Differentiation of Patient-Specific iPSCs into Cardiomyocytes Established iPSC lines from all subjects were differentiated into cardiomyocyte lineages (iPSC-CMs) using standard threedimensional (3D) EB differentiation protocols (Yang et al., 2008).”
MethodGrowth of engineered human myocardium with mechanical loading and vascular coculture
Tulloch, N. L., Muskheli, V., Razumova, M. V., Korte, F. S., Regnier, M., Hauch, K. D., Pabon, L., Reinecke, H., & Murry, C. E. (2011) · Circulation Research · doi:10.1161/circresaha.110.237206 · Cited by 666
A Platform for Generation of Chamber-Specific Cardiac Tissues and Disease Modeling
Zhao, Y., Rafatian, N., Feric, N. T., Cox, B. J., Aschar-Sobbi, R., Wang, E. Y., Aggarwal, P., Zhang, B., Conant, G., Ronaldson-Bouchard, K., et al. (2019) · Cell · doi:10.1016/j.cell.2018.11.042 · Cited by 610
“…(CMs) were derived from the human embryonic stem cell (hESC) lines HES2 (Female) and HES3-NKX2-5eGFP/w (Female) using the embryoid body (EB) (Yang et al., 2008) differentiation protocol and the human induced pluripotent stem cell (hiPSC) line BJ1D (male) (Nunes et al., 2013) using the…”
Self-citationCardioids reveal self-organizing principles of human cardiogenesis
Hofbauer, P., Jahnel, S. M., Papai, N., Giesshammer, M., Deyett, A., Schmidt, C., Penc, M., Tavernini, K., Grdseloff, N., Meledeth, C., et al. (2021) · Cell · doi:10.1016/j.cell.2021.04.034 · Cited by 588
Human ISL1 heart progenitors generate diverse multipotent cardiovascular cell lineages
Bu, L., Jiang, X., Martin-Puig, S., Caron, L., Zhu, S., Shao, Y., Roberts, D. J., Huang, P. L., Domian, I. J., & Chien, K. R. (2009) · Nature · doi:10.1038/nature08191 · Cited by 550
Dubois, N. C., Craft, A. M., Sharma, P., Elliott, D. A., Stanley, E. G., Elefanty, A. G., Gramolini, A., & Keller, G. (2011) · Nature Biotechnology · doi:10.1038/nbt.2005 · Cited by 544
Self-citationLiang, P., Lan, F., Lee, A. S., Gong, T., Sanchez-Freire, V., Wang, Y., Diecke, S., Sallam, K., Knowles, J. W., Wang, P. J., et al. (2013) · Circulation · doi:10.1161/circulationaha.113.001883 · Cited by 537
“Differentiation of Patient-Specific hiPSCs Into Cardiomyocytes Patient-specific hiPSCs were differentiated into cardiomyocytes using standard 3D EB differentiation protocols as previously described.(28) Differentiated EBs exhibited spontaneously contracting foci as early as ten days following initiation of cardiac dif…”
MethodChallenges in Cardiac Tissue Engineering
Vunjak-Novakovic, G., Tandon, N., Godier, A., Maidhof, R., Marsano, A., Martens, T. P., & Radisic, M. (2010) · Tissue Engineering Part B: Reviews · doi:10.1089/ten.teb.2009.0352 · Cited by 511
“hESC-derived cardiomyocytes have been considered the only source of exogenous myogenic cells for cardiac muscle replacement.(9,55,56) Just very recently the iPS cells, derived by reprogramming of adult human somatic cells, are emerging as another source of cells with the capacity to form muscle progenitors.”
InfluentialHarnessing the potential of induced pluripotent stem cells for regenerative medicine
Wu, S. M., & Hochedlinger, K. (2011) · Nature Cell Biology · doi:10.1038/ncb0511-497 · Cited by 506
Narazaki, G., Uosaki, H., Teranishi, M., Okita, K., Kim, B., Matsuoka, S., Yamanaka, S., & Yamashita, J. K. (2008) · Circulation · doi:10.1161/circulationaha.108.769562 · Cited by 476
Chu, L.-F., Leng, N., Zhang, J., Hou, Z., Mamott, D., Vereide, D. T., Choi, J., Kendziorski, C., Stewart, R., & Thomson, J. A. (2016) · Genome Biology · doi:10.1186/s13059-016-1033-x · Cited by 477
Pluripotent stem cells in regenerative medicine: challenges and recent progress
Tabar, V., & Studer, L. (2014) · Nature Reviews Genetics · doi:10.1038/nrg3563 · Cited by 458
Induced pluripotent stem cells: the new patient?
Bellin, M., Marchetto, M. C., Gage, F. H., & Mummery, C. L. (2012) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3448 · Cited by 431
Zhang, J., Klos, M., Wilson, G. F., Herman, A. M., Lian, X., Raval, K. K., Barron, M. R., Hou, L., Soerens, A. G., Yu, J., et al. (2012) · Circulation Research · doi:10.1161/circresaha.112.273144 · Cited by 445
Safe harbours for the integration of new DNA in the human genome
Sadelain, M., Papapetrou, E. P., & Bushman, F. D. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3179 · Cited by 441
Cardiomyocyte Differentiation of Human Induced Pluripotent Stem Cells
Zwi, L., Caspi, O., Arbel, G., Huber, I., Gepstein, A., Park, I.-H., & Gepstein, L. (2009) · Circulation · doi:10.1161/circulationaha.109.868885 · Cited by 435
Burridge, P. W., Thompson, S., Millrod, M. A., Weinberg, S., Yuan, X., Peters, A., Mahairaki, V., Koliatsos, V. E., Tung, L., & Zambidis, E. T. (2011) · PLoS ONE · doi:10.1371/journal.pone.0018293 · Cited by 417
“, and the formation of human embryoid bodies (hEB) with growth factor supplementation resulting in 23–60% of hEB contracting”
BackgroundStevens, K. R., Kreutziger, K. L., Dupras, S. K., Korte, F. S., Regnier, M., Muskheli, V., Nourse, M. B., Bendixen, K., Reinecke, H., & Murry, C. E. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0908381106 · Cited by 427
“Future studies will focus on testing alternative human cell sources (26, 27), developing techniques to create patches of appropriate size for epicardial treatment of large animals or for or injectable catheter-based delivery, and testing whether patches improve function after implantation on infarcted hearts.”
BackgroundNKX2-5eGFP/w hESCs for isolation of human cardiac progenitors and cardiomyocytes
Elliott, D. A., Braam, S. R., Koutsis, K., Ng, E. S., Jenny, R., Lagerqvist, E. L., Biben, C., Hatzistavrou, T., Hirst, C. E., Yu, Q. C., et al. (2011) · Nature Methods · doi:10.1038/nmeth.1740 · Cited by 426
Cardiomyocyte Regeneration: A Consensus Statement
Eschenhagen, T., Bolli, R., Braun, T., Field, L. J., Fleischmann, B. K., Frisén, J., Giacca, M., Hare, J. M., Houser, S., Lee, R. T., et al. (2017) · Circulation · doi:10.1161/circulationaha.117.029343 · Cited by 499
Self-citationCheung, C., Bernardo, A. S., Trotter, M. W. B., Pedersen, R. A., & Sinha, S. (2012) · Nature Biotechnology · doi:10.1038/nbt.2107 · Cited by 397
Mesp1 Acts as a Master Regulator of Multipotent Cardiovascular Progenitor Specification
Bondue, A., Lapouge, G., Paulissen, C., Semeraro, C., Iacovino, M., Kyba, M., & Blanpain, C. (2008) · Cell Stem Cell · doi:10.1016/j.stem.2008.06.009 · Cited by 388
Wu, B., Zhang, Z., Lui, W., Chen, X., Wang, Y., Chamberlain, A. A., Moreno-Rodriguez, R. A., Markwald, R. R., O’Rourke, B. P., Sharp, D. J., et al. (2012) · Cell · doi:10.1016/j.cell.2012.10.023 · Cited by 393
Bernardo, A. S., Faial, T., Gardner, L., Niakan, K. K., Ortmann, D., Senner, C. E., Callery, E. M., Trotter, M. W., Hemberger, M., Smith, J. C., et al. (2011) · Cell Stem Cell · doi:10.1016/j.stem.2011.06.015 · Cited by 386
“Fibroblast growth factor (FGF) in particular has been used to promote mesoderm specification and proliferation (Yang et al., 2008; Yook et al., 2011).”
BackgroundLu, T.-Y., Lin, B., Kim, J., Sullivan, M., Tobita, K., Salama, G., & Yang, L. (2013) · Nature Communications · doi:10.1038/ncomms3307 · Cited by 370
Self-citationZhang, Q., Jiang, J., Han, P., Yuan, Q., Zhang, J., Zhang, X., Xu, Y., Cao, H., Meng, Q., Chen, L., et al. (2011) · Cell Research · doi:10.1038/cr.2010.163 · Cited by 367
Protze, S. I., Liu, J., Nussinovitch, U., Ohana, L., Backx, P. H., Gepstein, L., & Keller, G. M. (2017) · Nature Biotechnology · doi:10.1038/nbt.3745 · Cited by 366
Self-citationHuman engineered heart tissue as a versatile tool in basic research and preclinical toxicology
Schaaf, S., Shibamiya, A., Mewe, M., Eder, A., Stöhr, A., Hirt, M. N., Rau, T., Zimmermann, W.-H., Conradi, L., Eschenhagen, T., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0026397 · Cited by 365
“Cardiomyocyte differentiation was performed with a modified EB-based, three-stage, growth factor cocktail protocol [2].”
MethodInfluentialGeneration of kidney organoids from human pluripotent stem cells
Takasato, M., Er, P. X., Chiu, H. S., & Little, M. H. (2016) · Nature Protocols · doi:10.1038/nprot.2016.098 · Cited by 342
Hao, T., Li, J., Yao, F., Dong, D., Wang, Y., Yang, B., & Wang, C. (2017) · ACS Nano · doi:10.1021/acsnano.7b00221 · Cited by 342
Developmental Fate and Cellular Maturity Encoded in Human Regulatory DNA Landscapes
Stergachis, A. B., Neph, S., Reynolds, A., Humbert, R., Miller, B., Paige, S. L., Vernot, B., Cheng, J. B., Thurman, R. E., Sandstrom, R., et al. (2013) · Cell · doi:10.1016/j.cell.2013.07.020 · Cited by 338
Blin, G., Nury, D., Stefanovic, S., Neri, T., Guillevic, O., Brinon, B., Bellamy, V., Rücker-Martin, C., Barbry, P., Bel, A., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci40120 · Cited by 325
“Plated on collagen 1-coated dishes, and treated with VEGF (50 ng/ml for 10 days), 80% to 90% of SSEA-1+ cells acquired the morphology of endothelial cells and expressed high level of CD31, CD34, and Flk1 mRNAs as well as the protein CD31 for 30 % of them (Supplemental figure 2C) but not cardiac troponin T (data not sh…”
BackgroundResultInfluentialPaige, S. L., Thomas, S., Stoick-Cooper, C. L., Wang, H., Maves, L., Sandstrom, R., Pabon, L., Reinecke, H., Pratt, G., Keller, G., et al. (2012) · Cell · doi:10.1016/j.cell.2012.08.027 · Cited by 328
Self-citationA Mesoderm-Derived Precursor for Mesenchymal Stem and Endothelial Cells
Vodyanik, M. A., Yu, J., Zhang, X., Tian, S., Stewart, R., Thomson, J. A., & Slukvin, I. I. (2010) · Cell Stem Cell · doi:10.1016/j.stem.2010.11.011 · Cited by 315
“…system that reproduces many aspects of early embryonic development and provides access to cells otherwise inaccessible in humans that represent the earliest stages of mesodermal commitment (Gadue et al., 2005; Kennedy et al., 2007; Kennedy et al., 1997; Yang et al., 2008; Zambidis et al., 2005).”
InfluentialResident c-kit+ cells in the heart are not cardiac stem cells
Sultana, N., Zhang, L., Yan, J., Chen, J., Cai, W., Razzaque, S., Jeong, D., Sheng, W., Bu, L., Xu, M., et al. (2015) · Nature Communications · doi:10.1038/ncomms9701 · Cited by 322
James, D., Nam, H.-S., Seandel, M., Nolan, D., Janovitz, T., Tomishima, M., Studer, L., Lee, G., Lyden, D., Benezra, R., et al. (2010) · Nature Biotechnology · doi:10.1038/nbt.1605 · Cited by 306
“In phase 1, heterogenous embryoid body cultures of hVPr-GFP hESCs were sequentially stimulated with bone morphogenetic protein (BMP)4, activinA, fibroblast growth factor (FGF)-2 and VEGF-”
MethodOrgan-on-a-chip platforms: a convergence of advanced materials, cells, and microscale technologies
Ahadian, S., Civitarese, R., Bannerman, D., Mohammadi, M. H., Lu, R., Wang, E., Davenport‐Huyer, L., Lai, B., Zhang, B., Zhao, Y., et al. (2018) · Advanced Healthcare Materials · doi:10.1002/adhm.201700506 · Cited by 315
Navarrete, E. G., Liang, P., Lan, F., Sanchez-Freire, V., Simmons, C., Gong, T., Sharma, A., Burridge, P. W., Patlolla, B., Lee, A. S., et al. (2013) · Circulation · doi:10.1161/circulationaha.112.000570 · Cited by 302
Efficient generation of human iPSCs by a synthetic self-replicative RNA
Yoshioka, N., Gros, E., Li, H.-R., Kumar, S., Deacon, D. C., Maron, C., Muotri, A. R., Chi, N. C., Fu, X.-D., Yu, B. D., et al. (2013) · Cell stem cell · doi:10.1016/j.stem.2013.06.001 · Cited by 312
The Systematic Production of Cells for Cell Therapies
Kirouac, D. C., & Zandstra, P. W. (2008) · Cell Stem Cell · doi:10.1016/j.stem.2008.09.001 · Cited by 301
“These tools are already being implemented for biopharmaceutical yield optimization (Diao et al., 2008) and as drug discovery platforms (Yang et al., 2008b) and could be quickly adapted to cell therapy bioprocess optimization (Gomez-Sjoberg et al., 2007).”
BackgroundUosaki, H., Fukushima, H., Takeuchi, A., Matsuoka, S., Nakatsuji, N., Yamanaka, S., & Yamashita, J. K. (2011) · PLoS ONE · doi:10.1371/journal.pone.0023657 · Cited by 298
“with the following modifications. Firstly, matrigel was added prior to induction to support cell survival during differentiation following a recent report (Zhang, Circulation, 2010: Abstract A20724). Secondly, we further added bFGF during d1-5 to enhance mesoderm differentiation and Dkk1 during d5-7 to improve cardiac…”
MethodCardiac Regenerative Capacity and Mechanisms
Kikuchi, K., & Poss, K. D. (2012) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev-cellbio-101011-155739 · Cited by 289
“Directed in vitro differentiation of ES cells or reprogrammed cells into cardiomyocytes is becoming efficient (Kattman et al 2011, Yang et al 2008).”
BackgroundIntroduction to Stem Cell Therapy
Biehl, J. K., & Russell, B. (2009) · Journal of Cardiovascular Nursing · doi:10.1097/jcn.0b013e318197a6a5 · Cited by 284
“Cells with the specific mesodermal marker, Kdr, give rise to the progenitor cells of the cardiovascular system including contracting cardiac myocytes, endothelial cells, and vascular smooth muscle cells and are therefore considered to be the earliest cells with specification toward the cardiovascular lineage.(17)”
Turning straw into gold: directing cell fate for regenerative medicine
Cohen, D. E., & Melton, D. (2011) · Nature Reviews Genetics · doi:10.1038/nrg2938 · Cited by 287
Signaling and Transcriptional Networks in Heart Development and Regeneration
Bruneau, B. G. (2013) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a008292 · Cited by 280
“Invitro, when differentiated from ES cells, the ckit+population varies in its potential forcardiogenesis (Wu et al. 2006; Yang et al. 2008; Zaruba et al. 2010).”
BackgroundKamakura, T., Makiyama, T., Sasaki, K., Yoshida, Y., Wuriyanghai, Y., Chen, J., Hattori, T., Ohno, S., Kita, T., Horie, M., et al. (2013) · Circulation Journal · doi:10.1253/circj.cj-12-0987 · Cited by 295
Use of differentiated pluripotent stem cells in replacement therapy for treating disease
Fox, I. J., Daley, G. Q., Goldman, S. A., Huard, J., Kamp, T. J., & Trucco, M. (2014) · Science · doi:10.1126/science.1247391 · Cited by 291
“(135), cardiac progenitors (136, 137), endothelial cells (ECs) (138), and smooth muscle cells (SMCs) (138), which have been tested in small-animal models.”
Induced Pluripotent Stem Cells 10 Years Later: For Cardiac Applications
Yoshida, Y., & Yamanaka, S. (2017) · Circulation Research · doi:10.1161/circresaha.117.311080 · Cited by 264
“Efficient cardiac myocyte induction using cytokines, such as Activin A and BMP4 (bone morphogenetic protein 4), was achieved in 2-dimensional monolayer and embryoid body–based differentiation systems.(53,54) The addition of chemical compounds that inhibit Wnt signaling was also shown to enhance the cardiac myocyte dif…”
MethodGoldfracht, I., Protze, S., Shiti, A., Setter, N., Gruber, A., Shaheen, N., Nartiss, Y., Keller, G., & Gepstein, L. (2020) · Nature Communications · doi:10.1038/s41467-019-13868-x · Cited by 263
Self-citationDeQuach, J. A., Mezzano, V., Miglani, A., Lange, S., Keller, G. M., Sheikh, F., & Christman, K. L. (2010) · PLoS ONE · doi:10.1371/journal.pone.0013039 · Cited by 262
“Human embryonic stem cells (hESCs, HES2, ESI International) were differentiated into beating embryoid bodies as previously described”
MethodSelf-citationDifferentiation of cardiomyocytes and generation of human engineered heart tissue
Breckwoldt, K., Letuffe-Brenière, D., Mannhardt, I., Schulze, T., Ulmer, B., Werner, T., Benzin, A., Klampe, B., Reinsch, M. C., Laufer, S., et al. (2017) · Nature Protocols · doi:10.1038/nprot.2017.033 · Cited by 272
Blinova, K., Stohlman, J., Vicente, J., Chan, D., Johannesen, L., Hortigon-Vinagre, M. P., Zamora, V., Smith, G., Crumb, W. J., Pang, L., et al. (2017) · Toxicological Sciences · doi:10.1093/toxsci/kfw200 · Cited by 272
“…required to differentiate human iPSCs into functional human cardiomyocytes (Burridge et al., 2012; Kattman et al., 2011; Laflamme et al., 2007; Yang et al., 2008) created the basis for the growing use of iPSC-CMs for cardiotoxicity screening of drugs (Clements and Thomas, 2014; Gibson et al.,…”
BackgroundSerena, E., Figallo, E., Tandon, N., Cannizzaro, C., Gerecht, S., Elvassore, N., & Vunjak-Novakovic, G. (2009) · Experimental Cell Research · doi:10.1016/j.yexcr.2009.08.015 · Cited by 269
Complete and unidirectional conversion of human embryonic stem cells to trophoblast by BMP4
Amita, M., Adachi, K., Alexenko, A. P., Sinha, S., Schust, D. J., Schulz, L. C., Roberts, R. M., & Ezashi, T. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1303094110 · Cited by 273
Mapping the first stages of mesoderm commitment during differentiation of human embryonic stem cells
Evseenko, D., Zhu, Y., Schenke-Layland, K., Kuo, J., Latour, B., Ge, S., Scholes, J., Dravid, G., Li, X., MacLellan, W. R., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1002077107 · Cited by 258
Composite scaffold provides a cell delivery platform for cardiovascular repair
Godier-Furnémont, A. F. G., Martens, T. P., Koeckert, M. S., Wan, L., Parks, J., Arai, K., Zhang, G., Hudson, B., Homma, S., & Vunjak-Novakovic, G. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1104619108 · Cited by 259
“G the adult heart’s minimal capacity for endogenous regeneration (1), cell therapy has emerged as a viable option for revascularization (2) and regeneration (3) of the infarct bed.”
BackgroundAhmed, R. E., Anzai, T., Chanthra, N., & Uosaki, H. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00178 · Cited by 250
Embryonic Heart Progenitors and Cardiogenesis
Brade, T., Pane, L. S., Moretti, A., Chien, K. R., & Laugwitz, K.-L. (2013) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a013847 · Cited by 254
“2) (Kouskoff et al. 2005; Kattman et al. 2006; Yang et al. 2008).”
Minami, I., Yamada, K., Otsuji, T. G., Yamamoto, T., Shen, Y., Otsuka, S., Kadota, S., Morone, N., Barve, M., Asai, Y., et al. (2012) · Cell Reports · doi:10.1016/j.celrep.2012.09.015 · Cited by 248
“Our method requires only small molecules that regulate WNT signaling, and not exogenous BMP4, Activin A, or bFGF, which are often used to increase efficiency of cardiac differentiation (Burridge et al., 2011; Yang et al., 2008).”
BackgroundMethodInfluentialCardiogenesis and the Complex Biology of Regenerative Cardiovascular Medicine
Chien, K. R., Domian, I. J., & Parker, K. K. (2008) · Science · doi:10.1126/science.1163267 · Cited by 251
Musunuru, K., Sheikh, F., Gupta, R. M., Houser, S. R., Maher, K. O., Milan, D. J., Terzic, A., & Wu, J. C. (2018) · Circulation: Genomic and Precision Medicine · doi:10.1161/hcg.0000000000000043 · Cited by 229
Mihic, A., Li, J., Miyagi, Y., Gagliardi, M., Li, S.-H., Zu, J., Weisel, R. D., Keller, G., & Li, R.-K. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2013.12.052 · Cited by 248
“Using a stage-specific cytokine inductionprotocol, these cells can be directed toward the cardiovascular lineages and produce cardiomyocytes [25].”
Self-citationCao, N., Liu, Z., Chen, Z., Wang, J., Chen, T., Zhao, X., Ma, Y., Qin, L., Kang, J., Wei, B., et al. (2012) · Cell Research · doi:10.1038/cr.2011.195 · Cited by 241
Maturing human pluripotent stem cell-derived cardiomyocytes in human engineered cardiac tissues
Feric, N. T., & Radisic, M. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.04.019 · Cited by 247
“Human PSC-CMs are generally differentiated by timed application of cardiogenic growth factors or small molecules with cells cultivated as either embryoid bodies (EBs) [20, 21] or in monolayers [22–25], and yield primarily CMs of the ventricular subtype.”
Gene Insertion Into Genomic Safe Harbors for Human Gene Therapy
Papapetrou, E. P., & Schambach, A. (2016) · Molecular Therapy · doi:10.1038/mt.2016.38 · Cited by 238
Transcriptional and Functional Profiling of Human Embryonic Stem Cell-Derived Cardiomyocytes
Cao, F., Wagner, R. A., Wilson, K. D., Xie, X., Fu, J.-D., Drukker, M., Lee, A., Li, R. A., Gambhir, S. S., Weissman, I. L., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003474 · Cited by 234
A regulatory pathway involving Notch1/β-catenin/Isl1 determines cardiac progenitor cell fate.
Kwon, C., Qian, L., Cheng, P., Nigam, V., Arnold, J., & Srivastava, D. (2009) · Nature Cell Biology · doi:10.1038/ncb1906 · Cited by 230
Pluripotent stem cell-derived cardiac tissue patch with advanced structure and function
Liau, B., Christoforou, N., Leong, K. W., & Bursac, N. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.08.050 · Cited by 233
“While this study suggests puromycin-selected Nkx2-5þ progenitors as the optimal source for cardiac tissue engineering, it is unknown if other cardiogenic cell sources, derived from pluripotent stemcells either bygenetic selection [7,63] ordirected differentiation [5,6], could yield engineered tissues with enhanced fun…”
ResultSelf-organized vascular networks from human pluripotent stem cells in a synthetic matrix
Kusuma, S., Shen, Y.-I., Hanjaya-Putra, D., Mali, P., Cheng, L., & Gerecht, S. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1306562110 · Cited by 225
“1E), similar to what has been recently reported for KDR+ EC derivatives (22).”
BackgroundInfluentialEfficient Detection and Purification of Cell Populations Using Synthetic MicroRNA Switches
Miki, K., Endo, K., Takahashi, S., Funakoshi, S., Takei, I., Katayama, S., Toyoda, T., Kotaka, M., Takaki, T., Umeda, M., et al. (2015) · Cell Stem Cell · doi:10.1016/j.stem.2015.04.005 · Cited by 218
“Although several studies on the differentiation of hPSCs into cardiomyocytes have been reported (Kawamura et al., 2013; Laflamme et al., 2007; Li et al., 2011; White et al., 2013; Yang et al., 2008), the resulting differentiated cells are often a mixture of heterogeneous populations.”
BackgroundSi-Tayeb, K., Noto, F. K., Sepac, A., Sedlic, F., Bosnjak, Z. J., Lough, J. W., & Duncan, S. A. (2010) · BMC Developmental Biology · doi:10.1186/1471-213x-10-81 · Cited by 220
“To ensure that the cells’ ability to differentiate in culture was not restricted to cells derived only from endodermal lineages, we examined the potential of the iPSK3 cells to differentiate toward a cardiac myocyte cell fate using a directed cardiac myocyte differentiation protocol based on previously published proce…”
MethodMohr, J. C., Zhang, J., Azarin, S. M., Soerens, A. G., de Pablo, J. J., Thomson, J. A., Lyons, G. E., Palecek, S. P., & Kamp, T. J. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2009.11.033 · Cited by 218
“Progress in using signaling molecules to direct differentiation of hESCs to cardiomyocytes has been made using Activin A, BMP4, bFGF, and Wnt signaling inhibitor [6,12].”
Zhu, W.-Z., Xie, Y., Moyes, K. W., Gold, J. D., Askari, B., & Laflamme, M. A. (2010) · Circulation Research · doi:10.1161/circresaha.110.223917 · Cited by 228
c-kit + precursors support postinfarction myogenesis in the neonatal, but not adult, heart
Jesty, S. A., Steffey, M. A., Lee, F. K., Breitbach, M., Hesse, M., Reining, S., Lee, J. C., Doran, R. M., Nikitin, A. Y., Fleischmann, B. K., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1208114109 · Cited by 223
Cardiovascular disease models: A game changing paradigm in drug discovery and screening
Savoji, H., Mohammadi, M. H., Rafatian, N., Toroghi, M. K., Wang, E. Y., Zhao, Y., Korolj, A., Ahadian, S., & Radisic, M. (2019) · Biomaterials · doi:10.1016/j.biomaterials.2018.09.036 · Cited by 223
Niebruegge, S., Bauwens, C. L., Peerani, R., Thavandiran, N., Masse, S., Sevaptisidis, E., Nanthakumar, K., Woodhouse, K., Husain, M., Kumacheva, E., et al. (2009) · Biotechnology and Bioengineering · doi:10.1002/bit.22065 · Cited by 222
“…2003; Passier et al., 2005) or serum-free cytokine induction (Kattman et al., 2006, 2007; Laflamme et al., 2007; Li et al., 2005; Ludwig et al., 2006; McDevitt et al., 2005; Passier et al., 2005; Xu et al., 2006b; Yang et al., 2008; Zhang et al., 2007), have been successfully derived from hESC.”
BackgroundA Complex Role for FGF-2 in Self-Renewal, Survival, and Adhesion of Human Embryonic Stem Cells
Eiselleova, L., Matulka, K., Kriz, V., Kunova, M., Schmidtova, Z., Neradil, J., Tichy, B., Dvorakova, D., Pospisilova, S., Hampl, A., et al. (2009) · Stem Cells · doi:10.1002/stem.128 · Cited by 213
c-kit expression identifies cardiovascular precursors in the neonatal heart
Tallini, Y. N., Greene, K. S., Craven, M., Spealman, A., Breitbach, M., Smith, J., Fisher, P. J., Steffey, M., Hesse, M., Doran, R. M., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0808920106 · Cited by 210
Human pluripotent stem cells: an emerging model in developmental biology
Zhu, Z., & Huangfu, D. (2013) · Development · doi:10.1242/dev.086165 · Cited by 202
“, 2005), to bone morphogenetic protein 4 (BMP4) and activin A for mesoderm differentiation (Yang et al., 2008), and to inhibitors of BMP and WNT signaling for ectoderm formation (Lamba et al.”
BackgroundDar, A., Domev, H., Ben-Yosef, O., Tzukerman, M., Zeevi-Levin, N., Novak, A., Germanguz, I., Amit, M., & Itskovitz-Eldor, J. (2012) · Circulation · doi:10.1161/circulationaha.111.048264 · Cited by 212
Islas, J. F., Liu, Y., Weng, K.-C., Robertson, M. J., Zhang, S., Prejusa, A., Harger, J., Tikhomirova, D., Chopra, M., Iyer, D., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1120299109 · Cited by 213
“Approximately 91% of these cells showed KDR/ PECAM1 cell surface markers representing cardiac mesodermal cells according to Kattman et al. (29).”
BackgroundInfluentialA Role for the Endothelium in Vascular Calcification
Yao, Y., Jumabay, M., Ly, A., Radparvar, M., Cubberly, M. R., & Boström, K. I. (2013) · Circulation Research · doi:10.1161/circresaha.113.301792 · Cited by 210
Expansion and patterning of cardiovascular progenitors derived from human pluripotent stem cells
Birket, M. J., Ribeiro, M. C., Verkerk, A. O., Ward, D., Leitoguinho, A. R., den Hartogh, S. C., Orlova, V. V., Devalla, H. D., Schwach, V., Bellin, M., et al. (2015) · Nature Biotechnology · doi:10.1038/nbt.3271 · Cited by 207
Metadata
- Authors
- Yang, L., Soonpaa, M. H., Adler, E. D., Roepke, T. K., Kattman, S. J., Kennedy, M., Henckaerts, E., Bonham, K., Abbott, G. W., Linden, R. M., Field, L. J., & Keller, G. M.
- Affiliations
- Icahn School of Medicine at Mount Sinai (US)
- Indiana University School of Medicine (US)
- Cornell University (US)
- University Health Network (CA)
- King's College London (GB)
- VistaGen Therapeutics (United States) (US)
- Corresponding author
- Keller, Gordon M.
- ORCID
- Venue
- Nature
- Published
- 2008-04-23
- Volume
- 453
- Issue
- 7194
- Pages
- 524-528
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2010417854
- Cited by
- 1,389
- References
- 30
- Citations by year
- 2026: 17 · 2025: 20 · 2024: 20 · 2023: 33 · 2022: 45 · 2021: 60 · 2020: 65 · 2019: 59 · 2018: 66 · 2017: 89 · 2016: 79 · 2015: 107 · 2014: 114 · 2013: 141 · 2012: 146
- FWCI
- 45.03
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Research Portal (King's College London) (submittedVersion)
- Lirias (submittedVersion)
- Funders
- National Institutes of Health
- National Heart, Lung, and Blood Institute (R01HL079275, R01HL083126)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Congenital heart defects research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Mesenchymal stem cell research
- Keywords
- human embryonic stem cells, cardiac progenitor cells, KDR, Flk-1, cardiomyocyte differentiation, endothelial differentiation, vascular smooth muscle cell differentiation, mesoderm specification, heart development, embryoid bodies, cell transplantation, cardiac regeneration, cardiovascular tissue engineering, lineage tracing, clonal origin, growth factor cocktail, activin A, BMP4, basic fibroblast growth factor
- MeSH terms
- Cell Differentiation, Cell Line, Humans, Fibroblast Growth Factor 2, Patch-Clamp Techniques, Proto-Oncogene Proteins c-kit, Cell Lineage, Bone Morphogenetic Proteins, Activins, Myocytes, Cardiac, Intercellular Signaling Peptides and Proteins, Vascular Endothelial Growth Factor Receptor-2, Vascular Endothelial Growth Factor A, Embryonic Stem Cells, Bone Morphogenetic Protein 4
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.